|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2011-3-30
|
|
pubmed:abstractText |
Paclitaxel (Taxol) and vinorelbine have shown synergism of cytotoxic effects in vitro and clinical activity in phase I and II studies. This combination was compared prospectively with the paclitaxel/gemcitabine regimen in non-operable non-small-cell lung cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1569-8041
|
|
pubmed:author |
pubmed-author:BafaloukosDD,
pubmed-author:BakogiannisCC,
pubmed-author:BoukovinasJJ,
pubmed-author:DimopoulosM AMA,
pubmed-author:EleftherakiA GAG,
pubmed-author:FountzilasGG,
pubmed-author:KalofonosH PHP,
pubmed-author:KatirtzoglouNN,
pubmed-author:KosmidisP APA,
pubmed-author:LambakiSS,
pubmed-author:PectasidesDD,
pubmed-author:PentheroudakisGG,
pubmed-author:SamantasEE,
pubmed-author:SkarlosDD,
pubmed-author:SyrigosK NKN
|
|
pubmed:copyrightInfo |
© The Author 2010. Published by Oxford University Press on behalf of the European Society for Medical Oncology.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
827-34
|
|
pubmed:meshHeading |
pubmed-meshheading:20880999-Adult,
pubmed-meshheading:20880999-Aged,
pubmed-meshheading:20880999-Aged, 80 and over,
pubmed-meshheading:20880999-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:20880999-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:20880999-Deoxycytidine,
pubmed-meshheading:20880999-Disease-Free Survival,
pubmed-meshheading:20880999-Drug Administration Schedule,
pubmed-meshheading:20880999-Female,
pubmed-meshheading:20880999-Greece,
pubmed-meshheading:20880999-Humans,
pubmed-meshheading:20880999-Lung Neoplasms,
pubmed-meshheading:20880999-Male,
pubmed-meshheading:20880999-Middle Aged,
pubmed-meshheading:20880999-Paclitaxel,
pubmed-meshheading:20880999-Vinblastine
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG).
|
|
pubmed:affiliation |
Department of Medical Oncology, Hygeia Hospital, Athens, Greece. parkosmi@otenet.gr
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Clinical Trial, Phase III
|
